PharmaIN

PharmaIN is a development-stage biopharmaceutical company focused on enabling and enhancing injectable therapies based on our proprietary and patented Protected Graft Copolymer (PGC™) drug delivery technology, which is licensed from Massachusetts General Hospital. We concentrate on extending the half-life and targeted delivery of proteins, peptides, siRNAs, and potent small molecule therapies.